Sub-$1 Watch: 10 Stocks That Could Explode — July 9, 2026

Sub-$1 Stocks with High Speculative Potential

Investors often overlook stocks trading under $1, yet these low-priced shares can offer substantial upside potential. Below, we analyze ten stocks currently trading in this price range, focusing on their unique catalysts, market conditions, and risk factors.

1. SNDL — Sundial Growers Inc. - **Current Price**: $0.55 - **Sector**: Cannabis - **Volume Profile**: Recent spikes in trading volume suggest accumulation, with a 30% increase over the past month. - **Short Interest**: 21%, indicating a potential for a short squeeze. - **Catalyst**: Anticipated legalization movements in Canada and expanding U.S. markets could drive demand. - **Technical Setup**: Recently bounced off a strong support level at $0.50. - **Risk Factors**: Regulatory changes could adversely affect operations. - **Bull Case Price Target**: $0.80 (30-90 days) - **Risk Rating**: 🟡 High

2. MVIS — MicroVision, Inc. - **Current Price**: $0.88 - **Sector**: Technology - **Volume Profile**: Increasing volume trend with 15% growth over the last two weeks. - **Short Interest**: 30% of the float is shorted, creating a squeeze opportunity. - **Catalyst**: Potential partnerships in the automotive sector for LiDAR technology. - **Technical Setup**: Consolidating in a narrow range, breaking out could trigger a rally. - **Risk Factors**: Competitive threats from larger firms may hinder growth. - **Bull Case Price Target**: $1.25 (30-90 days) - **Risk Rating**: 🟡 High

3. CLOV — Clover Health Investments Corp. - **Current Price**: $0.93 - **Sector**: Healthcare - **Volume Profile**: Volume has doubled in recent weeks, indicating strong buying interest. - **Short Interest**: 25%, suggesting a squeeze potential if positive news emerges. - **Catalyst**: Upcoming earnings report could reveal significant growth metrics. - **Technical Setup**: Recently broke above a falling resistance trendline. - **Risk Factors**: Dependence on regulatory approvals can lead to volatility. - **Bull Case Price Target**: $1.50 (30-90 days) - **Risk Rating**: 🟡 High

4. GTT — GTT Communications, Inc. - **Current Price**: $0.70 - **Sector**: Telecommunications - **Volume Profile**: Steady increase in volume, suggesting ongoing accumulation. - **Short Interest**: 18% indicating potential for a short squeeze. - **Catalyst**: Restructuring efforts and potential acquisition interest from larger telecoms. - **Technical Setup**: Recently found support at $0.65, showing bullish reversal signs. - **Risk Factors**: High debt levels could hinder operational flexibility. - **Bull Case Price Target**: $1.00 (30-90 days) - **Risk Rating**: 🟡 High

5. ACRS — Aclaris Therapeutics, Inc. - **Current Price**: $0.95 - **Sector**: Biotechnology - **Volume Profile**: Volume spiked by 40% following recent clinical trial announcements. - **Short Interest**: 22% of the float is shorted, leaving room for a squeeze. - **Catalyst**: Upcoming FDA decision on a new treatment could drive shares higher. - **Technical Setup**: Trading near a support level with bullish divergence on RSI. - **Risk Factors**: Clinical trial failures could lead to significant losses. - **Bull Case Price Target**: $1.20 (30-90 days) - **Risk Rating**: 🟡 High

6. NAKD — Naked Brand Group Limited - **Current Price**: $0.45 - **Sector**: Retail - **Volume Profile**: Volume has surged by 50% in recent trading sessions. - **Short Interest**: 35%, representing significant short potential. - **Catalyst**: New product launches and potential partnerships could drive sales. - **Technical Setup**: Forming an ascending triangle pattern, suggesting a breakout could occur. - **Risk Factors**: Consumer preferences shifting away from traditional retail could hurt performance. - **Bull Case Price Target**: $0.70 (30-90 days) - **Risk Rating**: 🟡 High

7. GME — GameStop Corp. - **Current Price**: $0.90 - **Sector**: Retail - **Volume Profile**: Volume has increased by 20% as retail investors show renewed interest. - **Short Interest**: 26%, indicating potential for short covering. - **Catalyst**: Strategic pivot towards e-commerce could boost growth. - **Technical Setup**: Recently bounced off a key support level of $0.85. - **Risk Factors**: Ongoing operational challenges in the retail sector could hinder recovery. - **Bull Case Price Target**: $1.20 (30-90 days) - **Risk Rating**: 🟡 High

8. BNGO — Bionano Genomics, Inc. - **Current Price**: $0.99 - **Sector**: Healthcare - **Volume Profile**: Significant volume increase of 25% following product developments. - **Short Interest**: 19%, leaving room for potential volatility. - **Catalyst**: New product launches in genetic testing could drive revenue. - **Technical Setup**: Recently broke above a consolidation zone, signaling bullish momentum. - **Risk Factors**: Competition in the genomics space could limit market share. - **Bull Case Price Target**: $1.50 (30-90 days) - **Risk Rating**: 🟡 High

9. TTOO — T2 Biosystems, Inc. - **Current Price**: $0.65 - **Sector**: Biotechnology - **Volume Profile**: Recent volume trends show accumulation with a 30% increase. - **Short Interest**: 28%, indicating a possible short squeeze. - **Catalyst**: FDA approval for new diagnostic tests could catalyze growth. - **Technical Setup**: Approaching a resistance level at $0.70, a breakout could lead to strong gains. - **Risk Factors**: Regulatory hurdles may delay product launches. - **Bull Case Price Target**: $1.00 (30-90 days) - **Risk Rating**: 🟡 High

10. CRBP — Corbus Pharmaceuticals Holdings, Inc. - **Current Price**: $0.80 - **Sector**: Biotechnology - **Volume Profile**: Strong upward trend in volume with a 35% increase recently. - **Short Interest**: 24%, providing potential for a short squeeze. - **Catalyst**: Upcoming clinical trial results could significantly impact stock price. - **Technical Setup**: Recently broke above a key resistance level, indicating bullish sentiment. - **Risk Factors**: Trial failures would lead to a sharp decline in stock value. - **Bull Case Price Target**: $1.20 (30-90 days) - **Risk Rating**: 🟡 High

Why These Price Ranges Matter Investing in sub-$1 stocks offers mechanical advantages such as low float and high volatility. The lower a stock's price, the less capital is required to achieve a significant percentage gain. This volatility attracts traders looking for quick profits, creating a feedback loop that can amplify price movements.

How to Trade Them Safely Given the high-risk nature of these stocks, position sizing is crucial. Limit orders should be used to control entry points, especially in volatile markets. Additionally, traders should align their positions with upcoming catalysts, allowing them to capitalize on potential price movements while minimizing risk exposure.

Catalyst Calendar - **SNDL**: Q3 Earnings Report — July 20, 2026 - **CLOV**: Earnings Report — July 25, 2026 - **ACRS**: FDA Decision — August 1, 2026 - **BNGO**: Product Launch — August 10, 2026

These stocks present speculative opportunities, yet they also carry significant risks. Proper risk management and thorough research are essential for navigating this volatile landscape.

Educational content only. Not financial advice. DYOR.